Results 11 to 20 of about 38,320 (161)

Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases

, 2021
Cardiovascular disease (CVD) is the leading cause of death worldwide. CVD includes a group of disorders of the heart and blood vessels such as myocardial infarction, ischemic heart, ischemic injury, injured arteries, thrombosis and atherosclerosis ...
Whittaker, Andrew K, Liu, Yajun, Zhang, Run, Vazquez-Prada, Karla X, Wu, Yuao, Ta, Hang T, Run Zhang, Karla X. Vazquez-Prada, Yajun Liu, Hang T. Ta, Yuao Wu, Andrew K. Whittaker   +11 more
core   +1 more source

Advanced Theranostic Nanomedicine in Oncology [PDF]

, 2020
Despite the vast and increasing scientific literature on the treatment of malicious diseases such as cancer, we are still far to accomplish most of the current unmet clinical desiderata.

core   +2 more sources

Dendrimers for theranostic applications

, 2023
Dendrimers are a class of monodisperse synthetic macromolecules that are interesting for high-end applications such as nanomedicine. The present chapter gives an overview of the proposed use of dendrimers and the derived dendrons for theranostic ...
Christensen, Jørn B., Mejlsøe, Søren Leth   +1 more
core   +1 more source

Animal Models for the Evaluation of Theranostic Radiopharmaceuticals

, 2021
Background: Theranostic is a new field of medicine that combines diagnosis and patient-specific targeted treatment. In the theranostic approach, it is aimed to detect diseased cells by using targeted molecules using disease-specific biological pathways ...
Durmus-Altun, Gulay, Soyluoglu, Selin
core   +1 more source

Zeolites for theranostic applications

, 2020
Theranostic platforms bring about a revolution in disease management. During recent years, theranostic nanoparticles have been utilized for imaging and therapy simultaneously.
Mashhadzadeh, Amin H., Saeb, Mohammad R., Hadi Hosseiniamoli, Ramsey, Joshua D., Amin Hamed Mashhadzadeh, Mohammad Reza Saeb, Masoud Mozafari, Yazdi, Mohsen K., Ganjali, Mohammad Reza, Zarrintaj, Payam, Hosseiniamoli, Hadi (R19348), Mohammad Reza Ganjali, Mozafari, Masoud, Payam Zarrintaj, Mohsen Khodadadi Yazdi, Joshua D. Ramsey   +15 more
core   +1 more source

Radiolabeling of Theranostic Nanosystems [PDF]

, 2021
In the recent years, progress in nanotechnology has significantly contributed to the development of novel pharmaceutical formulations to overcome the drawbacks of conventional treatments and improve the therapeutic outcome in many diseases, especially ...
Sarparanta, Mirkka, Sudeep Das, Surachet Imlimthan, Airaksinen, Anu, Das, Sudeep, Anu J. Airaksinen, Imlimthan, Surachet, Mirkka Sarparanta   +7 more
core   +1 more source

Theranostic applications of nanoparticles in neurodegenerative disorders

, 2018
Sahana Ramanathan,1 Govindaraju Archunan,2 Muthusamy Sivakumar,3 Subramanian Tamil Selvan,4 A Lenin Fred,5 Sundramurthy Kumar,1 Balázs Gulyás,1 Parasuraman Padmanabhan1 1Lee Kong Chian School of Medicine, Nanyang Technological University ...
Sivakumar M, Ramanathan S, Gulyás B, Padmanabhan P, Fred AL, Archunan G, Tamil Selvan S, Kumar S   +7 more
core   +2 more sources

Comprehensive intravascular imaging of atherosclerotic plaque in vivo using optical coherence tomography and fluorescence lifetime imaging

Scientific Reports, 2018
Comprehensive imaging of both the structural and biochemical characteristics of atherosclerotic plaque is essential for the diagnosis and study of coronary artery disease because both a plaque’s morphology and its biochemical composition affect the level
Min Woo Lee, Joon Woo Song, Woo Jae Kang, Hyeong Soo Nam, Tae Shik Kim, Sunwon Kim, Wang-Yuhl Oh, Jin Won Kim, Hongki Yoo   +8 more
doaj   +1 more source

Sphingolipidomics in Translational Sepsis Research–Biomedical Considerations and Perspectives

Frontiers in Medicine, 2021
Scientific Background: Sphingolipids are a highly diverse group of lipids with respect to physicochemical properties controlling either structure, distribution, or function, all of them regulating cellular response in health and disease.
Ralf A. Claus, Markus H. Graeler, Markus H. Graeler, Markus H. Graeler   +3 more
doaj   +1 more source

Optimisation of low and ultra-low dose scanning protocols for ultra-extended field of view PET in a real-world clinical setting

Cancer Imaging
True total-body and extended axial field-of-view (AFOV) PET/CT with 1m or more of body coverage are now commercially available and dramatically increase system sensitivity over conventional AFOV PET/CT.
Johanna Ingbritsen, Jason Callahan, Hugh Morgan, Melissa Munro, Robert E. Ware, Rodney J. Hicks   +5 more
doaj   +1 more source